Akums Drugs and Pharmaceuticals to attend investor meets on June 15
Akums Drugs and Pharmaceuticals Limited has scheduled investor and analyst meets for June 15, 2026, including the India Conclave Conference in Singapore and the Small-Cap Investor Conference in Mumbai. The company confirmed that no unpublished price sensitive information will be disclosed during these sessions. The schedule is subject to change based on exigencies.
*this image is generated using AI for illustrative purposes only.
Akums Drugs and Pharmaceuticals Limited has scheduled two investor and analyst meets for June 15, 2026, to engage with the investment community. The company will participate in the India Conclave Conference and the Small-Cap Investor Conference, both commencing at 09:00 A.M. (IST). These meetings provide a platform for the company to present its business outlook and operational performance directly to market participants.
The disclosure was made to the National Stock Exchange of India Ltd. and BSE Limited pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Akums Drugs & Pharma clarified that no unpublished price sensitive information will be shared during these interactions.
The meetings are categorized as group meets and will be held in two different locations. The schedule details are as follows:
| Sr. No. | Particulars of Meet | Date of Meeting | Type of Meet | Location / Mode of Meeting |
|---|---|---|---|---|
| 1. | India Conclave Conference | June 15, 2026 Starts at 09:00 A.M. (IST) |
Group Meet | Mandarin Oriental, 5 Raffles Avenue, Singapore |
| 2. | Small-Cap Investor Conference | June 15, 2026 Starts at 09:00 A.M. (IST) |
Group Meet | 3rd Floor, Platina, Bandra Kurla Complex, Mumbai |
The company noted that the schedule may be subject to change due to exigencies on the part of the host or the company. A copy of the disclosure has been updated on the official website of Akums Drugs and Pharmaceuticals Limited. Dharamvir Malik, Company Secretary & Compliance Officer, authorized the filing on June 10, 2026.
Historical Stock Returns for Akums Drugs & Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.74% | +12.66% | +16.16% | +45.38% | +8.30% | -21.41% |
What strategic initiatives or growth drivers is Akums likely to highlight during these investor meets?
How might the participation in the Small-Cap Investor Conference impact Akums' stock liquidity and investor interest?
Could the international location of the India Conclave Conference signal a push for expanding global investor base or partnerships?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
